Literature DB >> 24452507

Factors affecting survival after resection of intrahepatic cholangiocarcinoma.

Sae Murakami1, Tetsuo Ajiki, Taro Okazaki, Kimihiko Ueno, Masahiro Kido, Ippei Matsumoto, Takumi Fukumoto, Yonson Ku.   

Abstract

PURPOSE: This study aimed at assessing the prognostic factors of resection of intrahepatic cholangiocarcinoma (IHCC), which remain unclear.
METHODS: Among 70 patients with IHCC, who were admitted to our hospital between 1998 and 2011, 45 (64 %) underwent resection and 25 had unresectable tumors. Univariate and multivariate analyses were conducted retrospectively to assess the factors influencing survival of the patients who underwent resection.
RESULTS: The median survival times of the patients who underwent resection versus those who did not were 16 months versus 9 months, respectively (P < 0.001). Multivariate analysis identified residual tumor status (relative risk 4.12, P = 0.04) and pathological differentiation (relative risk 5.55, P = 0.04) as independent factors predicting survival. Patients who underwent R1 resection had a significantly higher rate of local recurrence than those who underwent R0 resection (P = 0.008). With R0 resection, there were no significant differences in patterns and rates of recurrence between patients with narrow (≤ 5 mm) versus wide (>5 mm) surgical margins.
CONCLUSIONS: R0/1 resection and a well-differentiated tumor were found to be independent prognostic factors for long-term survival after IHCC resection. If R0 resection was achieved, the width of the negative surgical margin did not affect the patterns and rates of recurrence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452507     DOI: 10.1007/s00595-013-0825-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  36 in total

1.  Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Kazuhisa Uchiyama; Masakazu Yamamoto; Hiroki Yamaue; Shun-ichi Ariizumi; Taku Aoki; Norihiro Kokudo; Tomoki Ebata; Masato Nagino; Masayuki Ohtsuka; Masaru Miyazaki; Eiichi Tanaka; Satoshi Kondo; Takahiro Uenishi; Shoji Kubo; Hiroshi Yoshida; Michiaki Unno; Satoru Imura; Mitsuo Shimada; Masaki Ueno; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-05       Impact factor: 7.027

2.  Intrahepatic cholangiocarcinoma: clinicopathological differences between peripheral type and hilar type.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2011-10-20       Impact factor: 3.452

3.  Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study.

Authors:  W F Shen; W Zhong; Q Liu; C J Sui; Y Q Huang; J M Yang
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

4.  Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma.

Authors:  Yuji Morine; Mitsuo Shimada; Tohru Utsunomiya; Satoru Imura; Tetsuya Ikemoto; Hiroki Mori; Jun Hanaoka; Mami Kanamoto; Hidenori Miyake
Journal:  Surg Today       Date:  2011-11-30       Impact factor: 2.549

5.  Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit.

Authors:  Akshat Saxena; Terence C Chua; Anik Sarkar; Francis Chu; David L Morris
Journal:  J Gastrointest Surg       Date:  2010-05-14       Impact factor: 3.452

6.  Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hiroki Ohge; Taijiro Sueda
Journal:  Ann Surg Oncol       Date:  2010-10-14       Impact factor: 5.344

7.  Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.

Authors:  Ken Shirabe; Yohei Mano; Akinobu Taketomi; Yuji Soejima; Hideaki Uchiyama; Shinichi Aishima; Hiroto Kayashima; Mizuki Ninomiya; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2010-02-05       Impact factor: 5.344

8.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

9.  Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients.

Authors:  Dario Ribero; Antonio Daniele Pinna; Alfredo Guglielmi; Antonio Ponti; Gennaro Nuzzo; Stefano Maria Giulini; Luca Aldrighetti; Fulvio Calise; Giorgio Enrico Gerunda; Mariano Tomatis; Marco Amisano; Pasquale Berloco; Guido Torzilli; Lorenzo Capussotti
Journal:  Arch Surg       Date:  2012-12

10.  Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma.

Authors:  Shohachi Suzuki; Takanori Sakaguchi; Yoshihiro Yokoi; Kazuya Okamoto; Kiyotaka Kurachi; Yasuo Tsuchiya; Takuya Okumura; Hiroyuki Konno; Satoshi Baba; Satoshi Nakamura
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

View more
  11 in total

1.  Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution.

Authors:  Ryota Higuchi; Takehiro Ota; Takehisa Yazawa; Hideki Kajiyama; Tatsuo Araida; Toru Furukawa; Tatsuya Yoshikawa; Ken Takasaki; Masakazu Yamamoto
Journal:  Surg Today       Date:  2015-02-05       Impact factor: 2.549

2.  Anatomical variations of liver blood supply in patients with pancreaticobiliary maljunction.

Authors:  Kenta Shinozaki; Tetsuo Ajiki; Taku Matsumoto; Yuko Yoshida; Sae Murakami; Taro Okazaki; Hirochika Toyama; Ippei Matsumoto; Takumi Fukumoto; Yonson Ku
Journal:  Surg Today       Date:  2015-02-05       Impact factor: 2.549

Review 3.  Surgical options for intrahepatic cholangiocarcinoma.

Authors:  Kui Wang; Han Zhang; Yong Xia; Jian Liu; Feng Shen
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

Review 4.  Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review.

Authors:  Linda Yang; Jocelyn Shan; Leonard Shan; Akshat Saxena; Lourens Bester; David L Morris
Journal:  J Gastrointest Oncol       Date:  2015-10

5.  Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis.

Authors:  Umberto Cillo; Gaya Spolverato; Alessandro Vitale; Aslam Ejaz; Sara Lonardi; David Cosgrove; Timothy M Pawlik
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

6.  Screening and surveillance for occupational cholangiocarcinoma in workers exposed to organic solvents.

Authors:  Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Takayoshi Nishioka; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Takatsugu Yamamoto; Makoto Abue; Masaru Aoki; Kei Nakagawa; Susumu Hijioka; Atsushi Miyamoto; Yukio Osaki; Ginji Endo; Shinji Kumagai
Journal:  Surg Today       Date:  2015-07-31       Impact factor: 2.549

7.  A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.

Authors:  Takuya Sakamoto; Shogo Kobayashi; Daisaku Yamada; Hiroaki Nagano; Akira Tomokuni; Yoshito Tomimaru; Takehiro Noda; Kunihito Gotoh; Tadafumi Asaoka; Hiroshi Wada; Koichi Kawamoto; Shigeru Marubashi; Hidetoshi Eguchi; Yuichiro Doki; Masaki Mori
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

8.  Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar Cholangiocarcinoma Resection.

Authors:  Tae Yoo; Sang-Jae Park; Sung-Sik Han; Seong Hoon Kim; Seung Duk Lee; Tae Hyun Kim; Soon-Ae Lee; Sang Myung Woo; Woo Jin Lee; Eun Kyung Hong
Journal:  Cancer Res Treat       Date:  2017-11-16       Impact factor: 4.679

9.  Intrahepatic cholangiocarcinoma in a patient with Wilson's disease: a case report.

Authors:  Yosuke Mukai; Hiroshi Wada; Hidetoshi Eguchi; Daisaku Yamada; Tadafumi Asaoka; Takehiro Noda; Koichi Kawamoto; Kunihito Gotoh; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yumiko Hori; Eiichi Morii; Yuichiro Doki; Masaki Mori
Journal:  Surg Case Rep       Date:  2016-03-23

10.  The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma: A single-center experience.

Authors:  Ka Wing Ma; Tan To Cheung; Wong Hoi She; Kenneth S H Chok; Albert Chi Yan Chan; Irene Oi Lin Ng; See Ching Chan; Chung Mau Lo
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.